CytoMed Therapeutics Ltd — All Filings
108 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
144
20-F
3
424B4
424B5
6-K
6-K/A
8-A12B
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0001493152-24-006594 | Feb 14, 2024 | — |
| 6-K | — | 0001493152-24-004055 | Jan 29, 2024 | — |
| 6-K | — | 0001493152-23-041779 | Nov 17, 2023 | Jun 30, 2023 |
| 6-K | — | 0001493152-23-033542 | Sep 25, 2023 | — |
| 6-K | — | 0001493152-23-026165 | Aug 1, 2023 | — |
| 6-K | — | 0001493152-23-023506 | Jul 6, 2023 | — |
| SC 13D | — | 0001493152-23-018344 | May 19, 2023 | — |
| 20-F | — | 0001493152-23-015042 | May 1, 2023 | Dec 31, 2022 |
| SC 13G | — | 0001493152-23-013398 | Apr 24, 2023 | — |
| SC 13D | — | 0001493152-23-013202 | Apr 21, 2023 | — |
| 6-K | — | 0001493152-23-012811 | Apr 18, 2023 | — |
| 424B4 | — | 0001493152-23-012534 | Apr 17, 2023 | — |
| 3 | — | 0001493152-23-012433 | Apr 17, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012430 | Apr 17, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012356 | Apr 14, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012350 | Apr 14, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012347 | Apr 14, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012343 | Apr 14, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012339 | Apr 14, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012337 | Apr 14, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012335 | Apr 14, 2023 | Mar 31, 2023 |
| 3 | — | 0001493152-23-012330 | Apr 14, 2023 | Mar 31, 2023 |
| CERT | 8A CERT | 0001354457-23-000281 | Apr 14, 2023 | — |
| SEC STAFF LETTER | — | 9999999997-23-001327 | Mar 31, 2023 | — |
| EFFECT | — | 9999999995-23-000774 | Mar 31, 2023 | — |
| CORRESP | — | 0001493152-23-010182 | Mar 31, 2023 | — |
| FWP | — | 0001493152-23-010165 | Mar 31, 2023 | — |
| CORRESP | — | 0001493152-23-010069 | Mar 31, 2023 | — |
| CORRESP | — | 0001493152-23-010063 | Mar 31, 2023 | — |
| 8-A12B | — | 0001493152-23-009686 | Mar 30, 2023 | — |
| CORRESP | — | 0001493152-23-009668 | Mar 30, 2023 | — |
| F-1/A | — | 0001493152-23-009652 | Mar 30, 2023 | — |
| UPLOAD | — | 0000000000-23-003153 | Mar 29, 2023 | — |
| F-1/A | — | 0001493152-23-009156 | Mar 28, 2023 | — |
| F-1/A | — | 0001493152-23-007810 | Mar 16, 2023 | — |
| CORRESP | — | 0001493152-23-007812 | Mar 15, 2023 | — |
| FWP | — | 0001493152-23-006101 | Feb 27, 2023 | — |
| UPLOAD | — | 0000000000-23-001896 | Feb 24, 2023 | — |
| CORRESP | — | 0001493152-23-005627 | Feb 21, 2023 | — |
| F-1/A | — | 0001493152-23-005626 | Feb 21, 2023 | — |
| UPLOAD | — | 0000000000-23-001347 | Feb 9, 2023 | — |
| F-1/A | — | 0001493152-23-003198 | Feb 1, 2023 | — |
| CORRESP | — | 0001493152-23-003199 | Jan 31, 2023 | — |
| SEC STAFF LETTER | — | 9999999997-22-004894 | Nov 30, 2022 | — |
| UPLOAD | — | 0000000000-22-012935 | Nov 30, 2022 | — |
| CORRESP | — | 0001493152-22-032839 | Nov 18, 2022 | — |
| F-1 | — | 0001493152-22-032838 | Nov 18, 2022 | — |
| UPLOAD | — | 0000000000-22-011485 | Oct 19, 2022 | — |
| DRS/A | — | 0001493152-22-027270 | Sep 30, 2022 | — |
| DRSLTR | — | 0001493152-22-001508 | Jan 18, 2022 | — |